:Griscelli syndrome type 2
{{Infobox medical condition (new)
| synonyms = Hypopigmentation-immunodeficiency with or without neurologic impairment syndrome
| name = Griscelli syndrome type 2
| image = Autosomal recessive - en.svg
| alt =
| caption = This condition is inherited in an autosomal recessive manner
| pronounce =
| field =
| geneReviewsID =
| symptoms =
| complications =
| onset =
| duration =
| types =
| causes =
| risks =
| diagnosis =
| differential =
| prevention =
| treatment =
| medication =
| prognosis =
| frequency =
| deaths =
}}
Griscelli syndrome type 2 (also known as "partial albinism with immunodeficiency") is a rare autosomal recessive syndrome characterized by variable cutenous albinism, silver colored metallic looking hair, frequent bacterial or viral infections, neutropenia, and thrombocytopenia.James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. {{ISBN|0-7216-2921-0}}.{{rp|866}}
Presentation
All types of Griscelli syndrome have distinctive skin and hair coloring.
Type 1 is associated with neurological abnormalities. These include delayed development, intellectual disability, seizures, hypotonia and eye abnormalities.
Type 2 - unlike type 1 - is not associated with primary neurological disease but is associated with an uncontrolled T lymphocyte expansion and macrophage activation syndrome. It is often associated with the hemophagocytic syndrome. This latter condition may be fatal in the absence of bone marrow transplantation.
Persons with type 3 have the typical light skin and hair coloring but are otherwise normal.
Genetics
There are three types of Griscelli syndrome.
Type 1 is associated with mutations in the MYO5A gene
Type 2 is associated with mutations in RAB27A gene.
Both these genes are located on the long arm of chromosome 15 (15q21).
Type 3 is associated with mutations in the MLPH gene.
All types are inherited in an autosomal recessive fashion.
Diagnosis
=Differential diagnosis=
This includes Chediak-Higashi syndrome and Elejalde syndrome (neuroectodermal melanolysosomal disease).
Treatment
{{Empty section|date=September 2017}}
History
This syndrome was first described in 1978.Griscelli C, Durandy, A, Guy-Grand D, Daguillard F, Herzog C, Prunieras M (1978) A syndrome associating partial albinism and immunodeficiency. Am J Med 65:691-702 In 2000 types 1 and 2 were distinguished.Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S, Wulffraat N, Bianchi D, Fischer A, Le Deist F, de Saint Basile G (2000) Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nature Genet 25:173-176
See also
References
{{reflist}}
External links
{{Medical resources
| DiseasesDB =
| ICD10 = E70.3
| ICD9 =
| ICDO =
| OMIM = 607624
| MedlinePlus =
| eMedicineSubj =
| eMedicineTopic =
| MeshID = C537302
| GeneReviewsName =
| Orphanet = 79477
}}
{{Pigmentation disorders}}
{{Deficiencies of intracellular signaling peptides and proteins}}